Immunophenotypic profile of tumor buds in breast cancer.

CONCLUSION: Most tumor buds (96.5%) share the same HR and Her2 expression profile of the main tumor mass, implying that tumor buds relay on the same pathways as the main tumor mass and might be equally responsive to targeted therapies. PMID: 29254793 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29254793?dopt=Abstract

Source: Pathology, Research and Practice - December 5, 2017 Category: Pathology Authors: Laedrach C, Salhia B, Cihoric N, Zlobec I, Tapia C Tags: Pathol Res Pract Source Type: research